Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.55 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 7/20 | 0.49 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15348811 | 0.81 | GAA (0.64) | L3MBTL1RAB9ANPC1SMN1; SMN2CASP1 | |
| SCHEMBL996720 | 0.80 | L3MBTL1 (0.55) | CSNK2A2CSNK2A1L3MBTL1RAB9ANPC1 | |
| SCHEMBL994563 | 0.77 | RAB9A (0.55) | L3MBTL1RAB9ANPC1SMN1; SMN2CASP1 | |
| SCHEMBL7209064 | 0.76 | RAB9A (0.76) | CSNK2A2CSNK2A1L3MBTL1RAB9ANPC1 | |
| SCHEMBL9634152 | 0.76 | L3MBTL1 (0.50) | CSNK2A2CSNK2A1L3MBTL1RAB9ANPC1 | |
| SCHEMBL7850474 | 0.73 | L3MBTL1 (0.51) | L3MBTL1RAB9ANPC1SMN1; SMN2CASP1 | |
| SCHEMBL6256084 | 0.73 | RAB9A (0.52) | CSNK2A2CSNK2A1L3MBTL1RAB9ANPC1 | |
| SCHEMBL6576665 | 0.73 | RAB9A (0.52) | CSNK2A2CSNK2A1L3MBTL1RAB9ANPC1 | |
| SCHEMBL2906397 | 0.73 | RAB9A (0.51) | L3MBTL1RAB9ANPC1SMN1; SMN2CASP1 | |
| SCHEMBL6675218 | 0.73 | TSHR (0.56) | L3MBTL1RAB9ANPC1SMN1; SMN2CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399160-A4 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | MERCK & CO INC (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1399160-A2 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | Merck & Co., Inc. (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002100352-A2 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | MERCK & CO., INC. (US) | 2002-12-19 | — | — | WO | disclosed |